200 related articles for article (PubMed ID: 31941718)
1. Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles Using Intrinsic Fluorescence.
Raut S; Garud A; Nagarajan B; Sabnis N; Remaley A; Fudala R; Gryczynski I; Gryczynski Z; Dzyuba SV; Borejdo J; Lacko A
J Pharmacol Exp Ther; 2020 Apr; 373(1):113-121. PubMed ID: 31941718
[TBL] [Abstract][Full Text] [Related]
2. Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.
Kornmueller K; Vidakovic I; Prassl R
Molecules; 2019 Aug; 24(15):. PubMed ID: 31382521
[TBL] [Abstract][Full Text] [Related]
3. Supramolecular Assembly of High-Density Lipoprotein Mimetic Nanoparticles Using Lipid-Conjugated Core Scaffolds.
Henrich SE; Hong BJ; Rink JS; Nguyen ST; Thaxton CS
J Am Chem Soc; 2019 Jun; 141(25):9753-9757. PubMed ID: 31177775
[TBL] [Abstract][Full Text] [Related]
4. High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.
Kuai R; Li D; Chen YE; Moon JJ; Schwendeman A
ACS Nano; 2016 Mar; 10(3):3015-41. PubMed ID: 26889958
[TBL] [Abstract][Full Text] [Related]
5. High-Density Lipoprotein Nanobiologics for Precision Medicine.
Mulder WJM; van Leent MMT; Lameijer M; Fisher EA; Fayad ZA; Pérez-Medina C
Acc Chem Res; 2018 Jan; 51(1):127-137. PubMed ID: 29281244
[TBL] [Abstract][Full Text] [Related]
6. Mimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructs.
Zhao Y; Imura T; Leman LJ; Curtiss LK; Maryanoff BE; Ghadiri MR
J Am Chem Soc; 2013 Sep; 135(36):13414-24. PubMed ID: 23978057
[TBL] [Abstract][Full Text] [Related]
7. Detecting the functional complexities between high-density lipoprotein mimetics.
Sei YJ; Ahn J; Kim T; Shin E; Santiago-Lopez AJ; Jang SS; Jeon NL; Jang YC; Kim Y
Biomaterials; 2018 Jul; 170():58-69. PubMed ID: 29653287
[TBL] [Abstract][Full Text] [Related]
8. Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a "molecular mop" in immune response.
Frame NM; Jayaraman S; Gantz DL; Gursky O
J Struct Biol; 2017 Dec; 200(3):293-302. PubMed ID: 28645735
[TBL] [Abstract][Full Text] [Related]
9. Peptide-Targeted High-Density Lipoprotein Nanoparticles for Combinatorial Treatment against Metastatic Breast Cancer.
Jiang C; Wang X; Teng B; Wang Z; Li F; Zhao Y; Guo Y; Zeng Q
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35248-35265. PubMed ID: 34284582
[TBL] [Abstract][Full Text] [Related]
10. Arrangement of apolipoprotein A-I in reconstituted high-density lipoprotein disks: an alternative model based on fluorescence resonance energy transfer experiments.
Tricerri MA; Behling Agree AK; Sanchez SA; Bronski J; Jonas A
Biochemistry; 2001 Apr; 40(16):5065-74. PubMed ID: 11305923
[TBL] [Abstract][Full Text] [Related]
11. Dual-modified natural high density lipoprotein particles for systemic glioma-targeting drug delivery.
Cui L; Wang Y; Liang M; Chu X; Fu S; Gao C; Liu Q; Gong W; Yang M; Li Z; Yu L; Yang C; Su Z; Xie X; Yang Y; Gao C
Drug Deliv; 2018 Nov; 25(1):1865-1876. PubMed ID: 30474437
[TBL] [Abstract][Full Text] [Related]
12. HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages.
Sanchez-Gaytan BL; Fay F; Lobatto ME; Tang J; Ouimet M; Kim Y; van der Staay SE; van Rijs SM; Priem B; Zhang L; Fisher EA; Moore KJ; Langer R; Fayad ZA; Mulder WJ
Bioconjug Chem; 2015 Mar; 26(3):443-51. PubMed ID: 25650634
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein mimetic nano-therapeutics targeting monocytes and macrophages for improved cardiovascular care: a comprehensive review.
Zhen J; Li X; Yu H; Du B
J Nanobiotechnology; 2024 May; 22(1):263. PubMed ID: 38760755
[TBL] [Abstract][Full Text] [Related]
14. A high-density lipoprotein-mediated drug delivery system.
Mo ZC; Ren K; Liu X; Tang ZL; Yi GH
Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):132-147. PubMed ID: 27208399
[TBL] [Abstract][Full Text] [Related]
15. Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.
Zhang X; Huang G
Drug Deliv; 2017 Dec; 24(sup1):16-21. PubMed ID: 29069931
[TBL] [Abstract][Full Text] [Related]
16. Development of novel HDL-mimicking α-tocopherol-coated nanoparticles to encapsulate nerve growth factor and evaluation of biodistribution.
Prathipati P; Zhu J; Dong X
Eur J Pharm Biopharm; 2016 Nov; 108():126-135. PubMed ID: 27531623
[TBL] [Abstract][Full Text] [Related]
17. The promise of apolipoprotein A-I mimetics.
Mendez AJ
Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):171-6. PubMed ID: 20125002
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of spheroidal, reconstituted high-density lipoproteins with apolipoprotein A-I only or with apolipoprotein A-I and A-II.
Rye KA; Garrety KH; Barter PJ
Biochim Biophys Acta; 1993 Apr; 1167(3):316-25. PubMed ID: 8481394
[TBL] [Abstract][Full Text] [Related]
19. Sensitive Morphological Characterization of Oriented High-Density Lipoprotein Nanoparticles Using
Lau S; Middleton DA
Angew Chem Int Ed Engl; 2020 Oct; 59(41):18126-18130. PubMed ID: 32542937
[TBL] [Abstract][Full Text] [Related]
20. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
